Delaying the Onset of Type 1 Diabetes with Teplizumab: A Narrative Review of Autoantibody Screening and Who Would Actually Be Treated. JCDO [Internet]. 2022 Oct. 10 [cited 2026 Oct. 30];2(1):7-12. Available from: https://pragmajournals.org/index.php/JCDO/article/view/316